Insight Holdings Group, an early backer of Hinge Health, sold 426,000 shares worth $38.4 million at $90.21 per share following the stock's 101% one-year appreciation. The sale was executed through a routine options exercise and immediate liquidation, not a complete exit, as the firm retains substantial derivative securities. Hinge Health continues to show strong fundamentals with Q1 revenue growth of 47% and expanding margins driven by AI automation.

The global digital health for musculoskeletal care market is projected to grow from $3.8 billion in 2025 to $10.9 billion by 2032, with a CAGR of 16.4%. Growth is driven by rising MSK disorder prevalence, wearable device adoption, AI-powered remote physiotherapy, telehealth expansion, and increasing insurance coverage for digital MSK solutions.

Hinge Health's co-founder Gabriel Mecklenburg sold 50,000 Class A shares worth $3.28 million on June 5, 2026. However, the article suggests this is not a major red flag as Mecklenburg retains 2.97 million shares in Class B holdings. The company shows strong fundamentals with 47% year-over-year sales growth, expanding margins (85% gross margin), and robust free cash flow generation ($41.6 million in Q1).

Smart ring maker Oura Health is preparing for an IPO that could serve as a key test for whether public markets are ready to support consumer-facing health technology companies. Unlike earlier wearable makers, Oura relies on a subscription model for health insights rather than just device sales. The company's debut comes as the digital health sector has undergone a repricing after pandemic-era excesses, with 620 digital health ventures exiting between 2023-2025 for $36.3 billion. However, Oura faces competition from tech giants like Apple and Samsung, and must prove it can scale beyond its core enthusiast base.

Hinge Health, a mid-cap healthcare stock focused on virtual musculoskeletal therapy, is gaining traction with insurers as a cost-reduction solution amid rising U.S. healthcare costs. The company reported 46% revenue growth and 23% EPS growth, exceeding estimates, with a study showing 56% lower spinal fusion surgery rates among its users. However, the stock faces headwinds from high stock-based compensation and projected revenue growth deceleration to 25% in 2026.

Hinge Health, a digital musculoskeletal health company that went public in May 2025, is rapidly growing with 51% revenue growth to $587.9 million in 2025 and expanding its corporate client base by 25% year-over-year. The company is leveraging AI-powered physical therapy solutions to help employers reduce healthcare costs and avoid expensive surgeries. Despite posting a net loss in 2025, it achieved $32 million in net income in Q4 and generated $61.5 million in free cash flow, with shares up only 7% since IPO, suggesting potential upside.

Hinge Health (HNGE) stock surged 7.99% after beating Q4 earnings expectations with $0.49 EPS on $170.7M in sales versus analyst forecasts of $0.43 EPS on $156.8M. The healthcare platform reported 46% YoY sales growth, expanded gross margins by 200 basis points, and generated $61.5M in free cash flow (up 65% YoY). The company forecasts 25% annual sales growth to $737M in 2026 with 29% non-GAAP earnings growth, trading at only 14.4x FCF.

In 2025, over 200 U.S. IPOs occurred, with less than a quarter beating the S&P 500's 18% return. Three standout performers were Karman (defense/aerospace, +230%), Circle Internet Group (stablecoin issuer, +150%), and Hinge Health (digital physical therapy, +45%), all significantly outperforming the broader market.

Connecticut-based fund Braidwell initiated a $44.7 million stake in Hinge Health during Q3, representing 1.8% of its assets under management. The digital health company has shown strong growth, with 53% year-over-year revenue increase and expanding enterprise client base.

Hinge Health, a digital physical therapy firm, had a strong debut on the NYSE, raising $273 million in its IPO. The stock surged 23% on its opening day, signaling a potential comeback for health-tech IPOs amid a sluggish tech IPO market.